SVETLANA REYBLAT: Open Payments
NPI 1518009497 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 28 payments from 14 companies in 2025. Trend: 2023 $545 · 2024 $513 · 2025 $815
Food & beverage: $735Education: $80
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $236 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| UCB, Inc. | 2 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Galderma Laboratories, L.P. | 2 | $70 |
| Lilly USA, LLC | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| ABBVIE INC. | 2 | $46 |
| Incyte Corporation | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $23 |
Products named: DUPIXENT, Bimzelx, TALTZ, SKYRIZI, OPZELURA, COSENTYX, TREMFYA, Zoryve.
Industry payments across FL — which companies pay providers there.
